SIMPLIMEDICA LTDActive

Company number SC409269Private limited companyIncorporated 2011

Key figures

£15,283-87.6%
Net assets 2024/25
-4.1%
Average annual change 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, SIMPLIMEDICA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets168,319255,497218,763225,086129,880
Total liabilities113,10165,22372,593101,915114,597
Net assets / total equity55,218186,505146,170123,17115,283
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Pharmaceutical Consultancy

As described in the company's latest filed accounts.

Summary: SIMPLIMEDICA LTD

Company

SIMPLIMEDICA LTD is a private limited company registered with Companies House under company number SC409269. It was incorporated on 12 Oct 2011. Its status is active. The registered office is in Edinburgh (EH3). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £15,283, down 87.6% on the previous year. Total assets were £129,880 and total liabilities £114,597. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 26 Oct 2026.